Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Augustin

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Molecular and Cellular Biology|August 29, 2012
GTPase ARFRP1 is essential for normal hepatic glycogen storage and insulin-like growth factor 1 secretionDeike Hesse, Alexander Jaschke, Timo Kanzleiter, et al.
Molecular Metabolism|December 3, 2015
TUSC5 regulates insulin-mediated adipose tissue glucose uptake by modulation of GLUT4 recyclingNigel Beaton, Carla Rudigier, Hansjörg Moest, et al.
The Journal of Biological Chemistry|July 30, 2008
ADP-ribosylation factor-like GTPase ARFRP1 is required for trans-Golgi to plasma membrane trafficking of E-cadherinClaudia Zahn, Alexander Jaschke, Jörg Weiske, et al.
Endocrinology|December 30, 2006
Ablation of the cholesterol transporter adenosine triphosphate-binding cassette transporter G1 reduces adipose cell size and protects against diet-induced obesityJana Buchmann, Christoph Meyer, Susanne Neschen, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 11, 2008
Neuronal functions, feeding behavior, and energy balance in Slc2a3+/- miceStefan Schmidt, Miriam Richter, Dirk Montag, et al.
Molecular Metabolism|November 10, 2022
BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacyTina Zimmermann, Leo Thomas, Tamara Baader-Pagler, et al.
Molecular Metabolism|July 6, 2025
Novel NPY2R agonist BI 1820237 provides synergistic anti-obesity efficacy when combined with the GCGR/GLP-1R dual agonist survodutideRobert Augustin, Anouk Oldenburger, Tamara Baader-Pagler, et al.
Molecular Metabolism|April 20, 2021
Challenges in tackling energy expenditure as obesity therapy: From preclinical models to clinical applicationMona C Löffler, Matthias J Betz, Denis P Blondin, et al.
Molecular Metabolism|February 4, 2026
Survodutide acts through circumventricular organs in the brain and activates neuronal regions associated with appetite regulationTina Zimmermann, Katherin Bleymehl, Peter Haebel, et al.
Molecular Metabolism|September 8, 2020
SGLT2 is not expressed in pancreatic α- and β-cells, and its inhibition does not directly affect glucagon and insulin secretion in rodents and humansHeeyoung Chae, Robert Augustin, Eva Gatineau, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Molecular and Cellular Biology|August 29, 2012
GTPase ARFRP1 is essential for normal hepatic glycogen storage and insulin-like growth factor 1 secretionDeike Hesse, Alexander Jaschke, Timo Kanzleiter, et al.
Molecular Metabolism|December 3, 2015
TUSC5 regulates insulin-mediated adipose tissue glucose uptake by modulation of GLUT4 recyclingNigel Beaton, Carla Rudigier, Hansjörg Moest, et al.
The Journal of Biological Chemistry|July 30, 2008
ADP-ribosylation factor-like GTPase ARFRP1 is required for trans-Golgi to plasma membrane trafficking of E-cadherinClaudia Zahn, Alexander Jaschke, Jörg Weiske, et al.
Endocrinology|December 30, 2006
Ablation of the cholesterol transporter adenosine triphosphate-binding cassette transporter G1 reduces adipose cell size and protects against diet-induced obesityJana Buchmann, Christoph Meyer, Susanne Neschen, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 11, 2008
Neuronal functions, feeding behavior, and energy balance in Slc2a3+/- miceStefan Schmidt, Miriam Richter, Dirk Montag, et al.
Molecular Metabolism|November 10, 2022
BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacyTina Zimmermann, Leo Thomas, Tamara Baader-Pagler, et al.
Molecular Metabolism|July 6, 2025
Novel NPY2R agonist BI 1820237 provides synergistic anti-obesity efficacy when combined with the GCGR/GLP-1R dual agonist survodutideRobert Augustin, Anouk Oldenburger, Tamara Baader-Pagler, et al.
Molecular Metabolism|April 20, 2021
Challenges in tackling energy expenditure as obesity therapy: From preclinical models to clinical applicationMona C Löffler, Matthias J Betz, Denis P Blondin, et al.
Molecular Metabolism|February 4, 2026
Survodutide acts through circumventricular organs in the brain and activates neuronal regions associated with appetite regulationTina Zimmermann, Katherin Bleymehl, Peter Haebel, et al.
Molecular Metabolism|September 8, 2020
SGLT2 is not expressed in pancreatic α- and β-cells, and its inhibition does not directly affect glucagon and insulin secretion in rodents and humansHeeyoung Chae, Robert Augustin, Eva Gatineau, et al.
Pageof 4